State of Wisconsin Investment Board acquired a new position in Syneron Medical Ltd. (NASDAQ:ELOS) during the second quarter, according to its most recent filing with the SEC. The institutional investor acquired 320,000 shares of the medical equipment provider’s stock, valued at approximately $3,504,000.

A number of other large investors also recently modified their holdings of the company. Two Sigma Securities LLC bought a new stake in shares of Syneron Medical during the first quarter worth approximately $164,000. PEAK6 Investments L.P. bought a new stake in shares of Syneron Medical during the first quarter worth approximately $111,000. Citadel Advisors LLC raised its stake in shares of Syneron Medical by 2.1% in the first quarter. Citadel Advisors LLC now owns 11,835 shares of the medical equipment provider’s stock worth $125,000 after buying an additional 243 shares in the last quarter. Menta Capital LLC bought a new stake in shares of Syneron Medical during the first quarter worth approximately $1,183,000. Finally, Bogle Investment Management L P DE raised its stake in shares of Syneron Medical by 71.9% in the first quarter. Bogle Investment Management L P DE now owns 198,453 shares of the medical equipment provider’s stock worth $2,093,000 after buying an additional 83,025 shares in the last quarter. 69.17% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Syneron Medical Ltd. (NASDAQ ELOS) opened at 11.00 on Friday. Syneron Medical Ltd. has a one year low of $6.18 and a one year high of $11.43. The firm’s 50-day moving average is $10.90 and its 200-day moving average is $10.14.

WARNING: This report was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/09/03/state-of-wisconsin-investment-board-acquires-new-position-in-syneron-medical-ltd-elos.html.

A number of brokerages have commented on ELOS. BidaskClub lowered shares of Syneron Medical from a “hold” rating to a “sell” rating in a report on Thursday, July 6th. Maxim Group lowered shares of Syneron Medical from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $12.00 to $11.00 in a report on Friday, May 12th.

Syneron Medical Company Profile

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Institutional Ownership by Quarter for Syneron Medical (NASDAQ:ELOS)

Receive News & Stock Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related stocks with our FREE daily email newsletter.